WorldPharmaNews
Search ...
Home
Business
Research
Events
Regulatory
GSK - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
www.gsk.com
GlaxoSmithKline RSS Channel
Filters
Display #
5
10
15
20
25
30
50
100
All
Filter
List of articles in category GlaxoSmithKline
Title
Published Date
GlaxoSmithKline successfully completes tender offer for shares of Genelabs Technologies, Inc.
08 January 2009
GlaxoSmithKline to cease providing corporate political contributions
23 December 2008
GSK analysis shows Seretide/Advair is a well tolerated and effective medicine
08 December 2008
GSK and Neptunus form joint venture for the co-development of flu vaccines
24 November 2008
GlaxoSmithKline to acquire Genelabs Technologies to increase focus on novel small molecule therapies
01 November 2008
GSKâs Emerging Markets strategy advances with acquisition in Egypt
20 October 2008
GSK responds to NICE's second technology appraisal consultation document on the use of Tyverb
15 October 2008
GlaxoSmithKline and Valeant Pharmaceuticals announce worldwide collaboration agreement
29 August 2008
GlaxoSmithKline and the Harvard Stem Cell Institute announce a unique collaboration
29 July 2008
GlaxoSmithKline teams up with academia to develop new medicines of value
22 July 2008
Start
Prev
14
15
16
17
18
19
20
21
22
23
Next
End
Business & Industry
Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology
Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
Bayer Consumer Health leaders propose new principles for science-led self-care
GSK signs agreement to support pandemic preparedness in Europe
Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design
Research & Development
Scientists create long-acting injectable drug delivery system for tuberculosis
Treating cancer by sticking cells in place
Vitamin K prevents cell death: a new function for a long-known molecule
Disparities in United States COVID-19 vaccine distribution
New needle-free nasal vaccine shows promise for COVID-19
Scientists develop new biomimetic formulation for treating glioblastoma
SARS-CoV-2 hijacks nanotubes between neurons to infect them
Conferences & Events
New approach to treatment of deadly kidney cancer
SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
SMi's 22nd Annual Pain Therapeutics Conference
SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
SMi's 3rd Annual AI in Drug Discovery Conference
Regulatory Affairs
FDA approves first systemic treatment for alopecia areata
FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
FDA limits use of Janssen COVID-19 vaccine to certain individuals
EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
FDA approves first generic of Symbicort to treat asthma and COPD
You are here:
Home
GlaxoSmithKline
GSK signs agreement to support pandemic preparedness in Europe